Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2003-06-09
2010-02-16
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C514S557000, C536S001110, C562S400000
Reexamination Certificate
active
07662863
ABSTRACT:
A therapeutic method and associated compound for ameliorating alcohol intoxication and preventing and/or reducing hangover symptoms. Glucaric acid, any salt thereof, and/or any derivative or metabolized form thereof is provided in therapeutic dosage, before and/or after the intake of alcohol.
REFERENCES:
patent: 4027017 (1977-05-01), Hata et al.
patent: 4058601 (1977-11-01), Hata et al.
patent: 4165376 (1979-08-01), Rosenberg
patent: 4845123 (1989-07-01), Walaszek et al.
patent: 5712309 (1998-01-01), Finnin et al.
patent: 5888532 (1999-03-01), Pritsos et al.
patent: 6045819 (2000-04-01), Takebe
patent: 6077838 (2000-06-01), Hausheer
patent: 6245360 (2001-06-01), Markowitx
patent: 2001/0000472 (2001-04-01), Henderson et al.
patent: 2001/0043956 (2001-11-01), Mirza et al.
patent: 2002/0006910 (2002-01-01), Miasnikov
patent: 2002/0142991 (2002-10-01), Herzenberg et al.
patent: 2002/0155103 (2002-10-01), Crippen
patent: 1291499 (2000-10-01), None
patent: 52072836 (1977-06-01), None
patent: 2160589 (1990-06-01), None
patent: 2 012 350 (1994-05-01), None
(no. authors given), “Calcium-D-Glucrate”. Alternative Medicine Review 2002, 7, 336-339.
Kamil, I. A.; Smith, J. N.; Williams, R. T. Biochemistry 1953, 53, 129-136.
Dutton et al. (Biochem, V 64(4), Dec. 1956, p. 693-701).
Ritz et al. (Z.ges exp.Med 153, 237-245 1970).
Walaszek et al. (Nutrition Research, vol. 16, 4, pp. 673-681, 1996).
Dwivedi et al., “Effect of Calcium Glucarate on β-Glucuronidase Activity and Glucarate Content of Certain Vegetables and Fruits,”Biochemical Medicine and Metabolic Biology, 1990; 43:83-92.
Walaszek et al., “Metabolism, Uptake, and Excretion of a D-Glucaric Acid Salt and its Potential Use in Cancer Prevention,”Cancer Detection and Prevention, 1997; 2(2):178-190.
Walaszek et al., “Repression by Sustained-Release β-Glucuronidase Inhibitors of Chemical Carcinogen-Mediated Induction of a Marker Oncofetal Protein in Rodents,”Journal of Toxicology and Environmental Health, 1988; 23:15-27.
Wiese et al., “The Alcohol Hangover,”Annals of Internal Medicine, 2000; 132(11):897-902.
Andrews Alan
Fields Christine
Minton Allison
Slaga Brian
Traci Sean
Padmanabhan Sreeni
Patton & Boggs LLP
Ramachandran Umamaheswari
LandOfFree
Therapeutic agent for the use in reducing alcohol... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for the use in reducing alcohol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for the use in reducing alcohol... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4206023